| 1999 |
Crystal structures of Sm protein complexes D3B and D1D2 revealed that SmE and other Sm proteins share a common fold with an N-terminal helix followed by a strongly bent five-stranded antiparallel beta sheet, and that the seven Sm proteins could form a closed ring structure through which snRNAs are bound in a positively charged central hole. |
X-ray crystallography of Sm protein complexes |
Cell |
High |
10025403
|
| 1997 |
SMN (the spinal muscular atrophy disease gene product) directly interacts with the spliceosomal Sm core protein SmE (SNRPE), forming a complex with SIP1 and multiple snRNP Sm proteins, suggesting a role for SMN in spliceosomal snRNP biogenesis. |
Co-immunoprecipitation, direct binding assays |
Cell |
High |
9323129
|
| 2001 |
The methylosome complex (containing JBP1/PRMT5 and pICln) binds Sm proteins via their Sm domains (pICln) and RG-rich domains (JBP1), producing symmetrical dimethylarginine modifications on SmD1 and SmD3 that direct these proteins to the SMN complex for assembly into snRNP core particles; SmE lacks RG-rich domains and is not a methylation substrate but participates in the pICln-Sm interactions. |
Co-immunoprecipitation, in vitro methyltransferase assay, mass spectrometry |
Molecular and cellular biology |
High |
11713266
|
| 1990 |
The expressed SNRPE gene (encoding snRNP protein E) was mapped to human chromosome 1q25-43, with most probable location at band 1q32, and identified as a single expressed gene among a multigene family containing processed pseudogenes. |
Somatic cell hybridization, in situ hybridization, linkage analysis |
Genomics |
Medium |
2143747
|
| 2002 |
SNRPE was identified as a core spliceosomal protein in affinity-purified, functional human spliceosomes, establishing it as part of the Sm core snRNP proteins present throughout spliceosome assembly. |
Maltose-binding protein affinity chromatography followed by nanoscale LC-MS/MS |
Nature |
High |
12226669
|
| 2012 |
Heterozygous mutations in SNRPE (c.1A>G causing loss of start codon, and c.133G>A [p.Gly45Ser]) cause autosomal-dominant hypotrichosis simplex. The c.1A>G mutation produces an N-terminally truncated protein using a downstream start codon. Both mutant proteins localize normally and incorporate into U snRNPs, suggesting the pathogenic mechanism is disruption of U snRNP splicing function rather than biogenesis. |
Direct sequencing, Western blot, immunofluorescence, snRNP incorporation assay in HEK293T cells |
American journal of human genetics |
Medium |
23246290
|
| 2019 |
A de novo heterozygous missense mutation in SNRPE (p.Phe22Ser) causes non-syndromal primary microcephaly and intellectual disability. The mutant SmE protein cannot interact with the SMN complex and consequently fails to assemble into U snRNPs, leading to widespread mRNA splicing alterations including mis-splicing of EMX2 (required for brain development). SmE depletion in zebrafish recapitulates aberrant splicing and reduced brain size. |
Co-immunoprecipitation (SMN complex interaction), RNA-seq (splicing alterations in patient fibroblasts and HEK293 cells), rescue experiments with wild-type vs. mutant SmE, zebrafish knockdown model |
PLoS genetics |
High |
31671093
|
| 2011 |
SNRPE knockdown by siRNA suppresses prostate cancer cell proliferation and reduces androgen receptor (AR) mRNA expression along with downstream AR target genes; conversely, SNRPE overexpression promotes cell proliferation, establishing that SNRPE regulates AR mRNA expression to support high-grade prostate cancer growth. |
siRNA knockdown, RT-PCR, cell proliferation assays, overexpression experiments |
Oncology letters |
Medium |
22740892
|
| 2024 |
SNRPE (activated transcriptionally by SOX2) acts as an oncofetal splicing factor in hepatocellular carcinoma; SNRPE knockdown reduces FGFR4 mRNA levels by triggering nonsense-mediated RNA decay (NMD) of mis-spliced FGFR4 transcripts, and FGFR4 knockdown partially phenocopies SNRPE loss, placing SNRPE upstream of FGFR4 in HCC tumorigenesis. |
RNA-seq (alternative splicing analysis), siRNA knockdown, NMD assays, in vitro and in vivo tumor assays, FGFR4 rescue experiments |
British journal of cancer |
Medium |
38796598
|
| 2025 |
In lung adenocarcinoma cells, SNRPE knockdown inhibits proliferation, induces G1 phase arrest, stimulates autophagy, and suppresses ERK/mTOR signaling activation, as evidenced by decreased phospho-ERK and phospho-mTOR and increased LC3B/Beclin1; tumor xenograft growth is also reduced. |
siRNA knockdown, Western blotting (ERK/mTOR pathway and autophagy markers), CCK-8/colony formation assays, flow cytometry, xenograft mouse model |
OncoTargets and therapy |
Low |
41268534
|
| 2025 |
SNRPE targeting in breast cancer cells triggers pyroptosis in a ROS-dependent manner, which activates NK cell-mediated antitumor immunity in vivo. |
siRNA/shRNA knockdown, xenograft murine model, ROS measurement, NK cell cytotoxicity assays |
International journal of medical sciences |
Low |
40386046
|
| 2026 |
In ovarian cancer, SNRPE deficiency causes intron 15 retention in CTPS1 mRNA, triggering NMD-mediated degradation of unspliced CTPS1 transcripts and reducing functional CTPS1 (the rate-limiting enzyme for CTP synthesis), thereby inducing G1 arrest and apoptosis; CTPS1 overexpression partially rescues SNRPE-knockdown phenotypes. |
RNA sequencing (splicing analysis), siRNA knockdown, NMD pathway assays, CTPS1 rescue overexpression, in vitro and in vivo tumor assays |
Oncogene |
Medium |
41933137
|
| 1997 |
Sequence comparison of the SNRPE gene promoter with those of the Sm-D1 gene and U1 snRNA genes revealed several homologous motifs, suggesting that genes encoding snRNP components including SNRPE may be coordinately regulated at the transcriptional level. |
CAT reporter gene fusion assay, DNA sequencing and promoter sequence comparison |
Gene |
Low |
9168134
|